Timothy Cloughesy
Director · UCLA David Geffen School of Medicine/UCLA Medical Center
Credentials: · · ·
History
- 1987–1988
- 1983–1987
Research
Journal of Clinical Oncology · 2010 · 3,116 citations
Bevacizumab plus radiotherapy-temozolomide for newly diagnosed glioblastoma
New England Journal of Medicine · 2014 · Last of 14 authors · 2,027 citations
Bevacizumab alone and in combination with irinotecan in recurrent glioblastoma
Journal of Clinical Oncology · 2009 · Last of 14 authors · 2,000 citations
162 papers · 1 as a fellow
145 papers · 3 as a fellow
136 papers · 1 as a fellow
- PW
130 papers
110 papers · 1 as a fellow
91 papers
69 papers
64 papers · 2 as a fellow
Grants
- 2022–2027
Role of Decorin and Diffusion MRI in Anti-VEGF Efficacy for Recurrent Glioblastoma
National Cancer Institute · R01
PI · $3M · University of California Los Angeles
- 2017–2022
National Cancer Institute · P50
Project lead · $368.7K · University of California Los Angeles
- 2003–2010
General Clinical Research Center
National Center for Research Resources · M01
Project lead · $952.7K · University of California Los Angeles
- 1998–2009
Computational Anatomy and Multidimensional Modeling
National Center for Research Resources · P41
Project lead · $249.3K · University of California Los Angeles
Clinical trials
- 2020–2026
Principal investigator · Completed · Phase 1
Jonsson Comprehensive Cancer Center
- 2019–2022
Principal investigator · Withdrawn · Phase 2
Jonsson Comprehensive Cancer Center
- 2018–2024
Principal investigator · Completed · Phase 2
Jonsson Comprehensive Cancer Center
- 2016–2024
Lapatinib Ditosylate Before Surgery in Treating Patients With Recurrent High-Grade Glioma
Principal investigator · Completed · Phase 1
National Cancer Institute (NCI)